Healthcare Infection Control Practices Advisory Committee, (HICPAC), 24859-24860 [E9-12119]

Download as PDF Federal Register / Vol. 74, No. 99 / Tuesday, May 26, 2009 / Notices organizations), our review and evaluation of AOA will be conducted in accordance with, but not necessarily limited to, the following factors: • The equivalency of AOA’s standards for an ASC as compared with CMS’ ASC conditions for coverage. • AOA’s survey process to determine the following: —The composition of the survey team, surveyor qualifications, and the ability of the organization to provide continuing surveyor training. —The comparability of AOA’s processes to those of State agencies, including survey frequency, and the ability to investigate and respond appropriately to complaints against accredited facilities. —AOA’s processes and procedures for monitoring ASCs found out of compliance with AOA’s program requirements. These monitoring procedures are used only when AOA identifies noncompliance. If noncompliance is identified through validation reviews, the State survey agency monitors corrections as specified at § 488.7(d). —AOA’s capacity to report deficiencies to the surveyed facilities and respond to the facility’s plan of correction in a timely manner. —AOA’s capacity to provide us with electronic data and reports necessary for effective validation and assessment of the organization’s survey process. —The adequacy of AOA’s staff and other resources, and its financial viability. —AOA’s capacity to adequately fund required surveys. —AOA’s policies with respect to whether surveys are announced or unannounced, to assure that surveys are unannounced. —AOA’s agreement to provide us with a copy of the most current accreditation survey together with any other information related to the survey as we may require (including corrective action plans). IV. Collection of Information Requirements This document does not impose information collection and recordkeeping requirements. Consequently, it need not be reviewed by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 35). V. Response to Comments Because of the large number of public comments we normally receive on Federal Register documents, we are not VerDate Nov<24>2008 20:08 May 22, 2009 Jkt 217001 able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the DATES section of this preamble, and, when we proceed with a subsequent document, we will respond to the comments in the preamble to that document. (Catalog of Federal Domestic Assistance Program No. 93.778, Medical Assistance Program; No. 93.773 Medicare—Hospital Insurance Program; and No. 93.774, Medicare—Supplementary Medical Insurance Program) Dated: April 30, 2009. Charlene Frizzera, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. E9–12109 Filed 5–22–09; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee H—Clinical Groups. Date: July 20–21, 2009. Time: 8 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Timothy C. Meeker, MD, PhD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8103, Bethesda, MD 20892. (301) 594–1279. meekert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 24859 Cancer Control, National Institutes of Health, HHS) Dated: May 18, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–12201 Filed 5–22–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee, (HICPAC) In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: Times and Dates: 9 a.m.–5 p.m., June 15, 2009. 9 a.m.–12 p.m., June 16, 2009. Place: CDC, Tom Harkin Global Communications Center (Building 19), Auditorium B3, 1600 Clifton Road, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The Committee is charged with providing advice and guidance to the Secretary, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), regarding: (1) The practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters to be Discussed: The agenda will include a follow up discussion of Health and Human Services Healthcare-Associated Infections (HAI) elimination plan, Norovirus Guideline, and Healthcare Personnel Infection Control Guideline. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Wendy Vance, Committee Management Specialist, Division of Healthcare Quality Promotion, NCPDCID, CDC, l600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333 Telephone (404) 639–2891. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\26MYN1.SGM 26MYN1 24860 Federal Register / Vol. 74, No. 99 / Tuesday, May 26, 2009 / Notices Dated: May 18, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E9–12119 Filed 5–22–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following teleconference meetings: Times and Dates: 12:30 p.m.–12:45 p.m., June 22, 2009 (Open). 12:45 p.m.–7 p.m., June 22, 2009 (Closed). 9 a.m.–9:15 a.m., June 23, 2009 (Open). 9:15 a.m.–5 p.m., June 23, 2009 (Closed). 9 a.m.–9:15 a.m., June 24, 2009 (Open). 9:15 a.m.–5 p.m., June 24, 2009 (Closed). 9 a.m.–9:15 a.m., June 25, 2009 (Open). 9:15 a.m.–5 p.m., June 25, 2009 (Closed). Place: Teleconference, Toll Free: 877–468– 4185, Participant Pass Code: 3772769. Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control. Matters To Be Discussed: The meetings will include the review, discussion, and evaluation of applications submitted in response to Fiscal Year 2009 Requests for Applications related to the following individual research announcement: RFA– EH–09–001 Climate Change: Environmental Impact on Human Health (U01). Agenda items are subject to change as priorities dictate. CONTACT PERSON FOR MORE INFORMATION: Rick Waxweiler, Ph.D., Director, Extramural Research Program Office, National Center for Injury Prevention & Control and Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, N.E., M/S F–62, Atlanta, Georgia 30341, Telephone 770–488-4850. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices Jkt 217001 Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427–1554. Agenda items for this meeting are subject to change as priorities dictate. Dated: May 15, 2009. Carolyn M. Clancy, Director. [FR Doc. E9–12068 Filed 5–22–09; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Center for Injury Prevention and Control Initial Review Group, (NCIPC IRG) 20:08 May 22, 2009 Dated: May 18, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–12120 Filed 5–22–09; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention VerDate Nov<24>2008 pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Meeting In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the Accelerating Development of Methods for the Study of Complex Patients (R21) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: Accelerating Development of Methods for the Study of Complex Patients (R21). Date: June 23, 2009 (Open on June 23 from 1 p.m. to 1:15 p.m. and closed for the remainder of the meeting). Place: Agency for Healthcare Research and Quality, John Eisenberg Building, Conference Center, Rockville, Maryland 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the nonconfidential portions of this meeting should contact Mrs. Bonnie Campbell, PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Pediatric Functional Neuroimaging Research Network. Date: June 26, 2009. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate contract proposals Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Sathasiva B. Kandasamy, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892–9304, (301) 435–6680, skandasa@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) E:\FR\FM\26MYN1.SGM 26MYN1

Agencies

[Federal Register Volume 74, Number 99 (Tuesday, May 26, 2009)]
[Notices]
[Pages 24859-24860]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12119]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee, 
(HICPAC)

    In accordance with section 10(a) (2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:

    Times and Dates: 9 a.m.-5 p.m., June 15, 2009. 9 a.m.-12 p.m., 
June 16, 2009.
    Place: CDC, Tom Harkin Global Communications Center (Building 
19), Auditorium B3, 1600 Clifton Road, Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, the Assistant Secretary for Health, the 
Director, CDC, and the Director, National Center for Preparedness, 
Detection, and Control of Infectious Diseases (NCPDCID), regarding: 
(1) The practice of hospital infection control; (2) strategies for 
surveillance, prevention, and control of infections (e.g., 
nosocomial infections), antimicrobial resistance, and related events 
in settings where healthcare is provided; and (3) periodic updating 
of guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters to be Discussed: The agenda will include a follow up 
discussion of Health and Human Services Healthcare-Associated 
Infections (HAI) elimination plan, Norovirus Guideline, and 
Healthcare Personnel Infection Control Guideline.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Wendy Vance, Committee 
Management Specialist, Division of Healthcare Quality Promotion, 
NCPDCID, CDC, l600 Clifton Road, NE., Mailstop A-07, Atlanta, 
Georgia 30333 Telephone (404) 639-2891.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.


[[Page 24860]]


    Dated: May 18, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
 [FR Doc. E9-12119 Filed 5-22-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.